| Title | Cancer Biomarkers |
| Standard Abbreviation | Cancer Biomark. |
| Type of Publication | Journal |
| Discipline | Medicine (miscellaneous) (Q2); Cancer Research (Q3); Genetics (Q3); Oncology (Q3) |
| Impact Score | 2.86 |
| SCImago Journal Rank (SJR) | 0.622 |
| h-index | 50 |
| Overall Rank | 8223 |
| Publisher Name | IOS Press BV |
| Publication Country | Netherlands |
| International Standard Serial Number (ISSN) | 15740153, 18758592 |
| Coverage and History | 2005-2022 |
| Best Quartile | Q2 |
| Total Citations Received (Last 3 Year) |
1297 |
Cancer Biomarkers is a journal published by IOS Press BV. This journal covers the area[s] related to Medicine (miscellaneous), Cancer Research, Genetics, Oncology, etc.
The coverage history of this journal is as follows: 2005-2022.
The rank of this journal is 8223. This journal's impact score, h-index, and SJR are 2.86, 50, and 0.622, respectively. The ISSN of this journal is/are as follows: 15740153, 18758592.
The best quartile of Cancer Biomarkers is Q2.
This journal has received a total of 1297 citations during the last three years (Preceding 2022).
The latest impact score (IS) of the Cancer Biomarkers is 2.86. It is computed in the year 2023 as per its definition and based on Scopus data.
2.86
It is decreased by a factor of around 0.69, and the percentage change is -19.44% compared to the preceding year 2021, indicating a falling trend.
The impact score (IS), also denoted as the Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
Impact Score 2022 of Cancer Biomarkers is 2.86. If a similar downward trend continues, IS may decrease in 2023 as well.
| Year | Impact Score (IS) |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 2.86 |
| 2021 | 3.55 |
| 2020 | 3.83 |
| 2019 | 3.08 |
| 2018 | 2.70 |
| 2017 | 2.54 |
| 2016 | 2.40 |
| 2015 | 1.89 |
| 2014 | 1.87 |
The h-index of Cancer Biomarkers is 50. By definition of the h-index, this journal has at least 50 published articles with more than 50 citations.
The h-index (also known as the Hirsch index or Hirsh index) is a scientometric parameter used to evaluate the scientific impact of the publications and journals. It is defined as the maximum value of h such that the given Journal has published at least h papers and each has at least h citations.
The International Standard Serial Number (ISSN) of Cancer Biomarkers is/are as follows: 15740153, 18758592.
The ISSN is a unique 8-digit identifier for a specific publication like Magazine or Journal. The ISSN is used in the postal system and in the publishing world to identify the articles that are published in journals, magazines, newsletters, etc. This is the number assigned to your article by the publisher, and it is the one you will use to reference your article within the library catalogues.
ISSN code (also called as "ISSN structure" or "ISSN syntax") can be expressed as follows: NNNN-NNNC
Here, N is in the set {0,1,2,3...,9}, a digit character, and C is in {0,1,2,3,...,9,X}
The Cancer Biomarkers is ranked 8223 among 27955 Journals, Conferences, and Book Series.
As per SJR, this journal is ranked 0.622.
SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
The publisher of Cancer Biomarkers is IOS Press BV. The publishing house of this journal is located in the Netherlands. Its coverage history is as follows: 2005-2022.
Please check the official website of this journal to find out the complete details and Call For Papers (CFPs).
The International Organization for Standardization 4 (ISO 4) abbreviation of Cancer Biomarkers is Cancer Biomark.. ISO 4 is an international standard which defines a uniform and consistent system for the abbreviation of serial publication titles, which are published regularly. The primary use of ISO 4 is to abbreviate or shorten the names of scientific journals using the technique of List of Title Word Abbreviations (LTWA).
As ISO 4 is an international standard, the abbreviation ('Cancer Biomark.') can be used for citing, indexing, abstraction, and referencing purposes.
If your area of research or discipline is related to Medicine (miscellaneous), Cancer Research, Genetics, Oncology, etc., please check the journal's official website to understand the complete publication process.
There are several factors that influence the acceptance rate of any academic journal. Here are some critical parameters that are considered while calculating the acceptance rate:
The simplest way to find out the acceptance rate or rejection rate of a Journal/Conference is to check with the journal's/conference's editorial team through emails or through the official website.
The latest impact score of Cancer Biomarkers is 2.86. It is computed in the year 2023.
The latest h-index of Cancer Biomarkers is 50. It is evaluated in the year 2023.
The latest SCImago Journal Rank (SJR) of Cancer Biomarkers is 0.622. It is calculated in the year 2023.
The latest ranking of Cancer Biomarkers is 8223. This ranking is among 27955 Journals, Conferences, and Book Series. It is computed in the year 2023.
Cancer Biomarkers is published by IOS Press BV. The publication country of this journal is Netherlands.
This standard abbreviation of Cancer Biomarkers is Cancer Biomark..
Cancer Biomarkers is a journal published by IOS Press BV.
The scope of Cancer Biomarkers is as follows:
For detailed scope of Cancer Biomarkers, check the official website of this journal.
The International Standard Serial Number (ISSN) of Cancer Biomarkers is/are as follows: 15740153, 18758592.
The best quartile for Cancer Biomarkers is Q2.
The coverage history of Cancer Biomarkers is as follows 2005-2022.
Note: The impact score shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.
| Journal/Conference/Book Title | Type | Publisher | Ranking | SJR | h-index | Impact Score |
|---|---|---|---|---|---|---|
| Journal of Academic Ethics | Journal | Springer Netherlands | 8920 | 26 | 2.28 | |
| Journal of Geriatric Physical Therapy | Journal | Lippincott Williams and Wilkins Ltd. | 5578 | 43 | 1.80 | |
| Journal of Competition Law and Economics | Journal | Oxford University Press | 14815 | 29 | 0.72 | |
| International Journal of Applied Linguistics | Journal | Wiley-Blackwell Publishing Ltd | 7321 | 51 | 2.00 | |
| Canadian Journal of Education | Journal | Canadian Society for the Study of Education (CSSE) | 17961 | 41 | 0.39 | |
| Journal, Indian Academy of Clinical Medicine | Journal | Indian Academy of Clinical Medicine | 24608 | 16 | 0.06 | |
| Sex Education | Journal | Routledge | 5168 | 41 | 2.82 | |
| Epigenetics | Journal | Landes Bioscience | 2362 | 105 | 4.11 | |
| Proteomics - Clinical Applications | Journal | Wiley-VCH Verlag | 9140 | 59 | 2.02 | |
| English Literary Renaissance | Journal | University of Chicago Press | 23442 | 20 | 0.25 |
| Year | Impact Score (IS) |
|---|---|
| 2023/2024 | Updated Soon |
| 2022 | 2.86 |
| 2021 | 3.55 |
| 2020 | 3.83 |
| 2019 | 3.08 |
| 2018 | 2.70 |
| 2017 | 2.54 |
| 2016 | 2.40 |
| 2015 | 1.89 |
| 2014 | 1.87 |
2.86
0.622
50
8223
